mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathwaysPradip K. Majumder, William R. Sellers, Phillip G. Febbo et al.|Nature Medicine|2004Cited by 956
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion CohortLaura Q.M. Chow, Tanguy Y. Seiwert, Robert I. Haddad et al.|Journal of Clinical Oncology|2016Cited by 859
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian CancerTimothy R. Rebbeck, Saundra S. Buys, Georgia Chenevix‐Trench et al.|JAMA|2015Cited by 507
Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial CellsRaanan Berger, William C. Hahn|Cancer Research|2004Cited by 175
Antitumor activity and safety of pembrolizumab in patients (pts) with advanced squamous cell carcinoma of the head and neck (SCCHN): Preliminary results from KEYNOTE-012 expansion cohort.Tanguy Y. Seiwert, Laura Q.M. Chow, Robert I. Haddad et al.|Journal of Clinical Oncology|2015Cited by 103